These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 26990147)
1. Human rhinovirus in experimental infection after peroral Lactobacillus rhamnosus GG consumption, a pilot study. Tapiovaara L; Kumpu M; Mäkivuokko H; Waris M; Korpela R; Pitkäranta A; Winther B Int Forum Allergy Rhinol; 2016 Aug; 6(8):848-53. PubMed ID: 26990147 [TBL] [Abstract][Full Text] [Related]
2. Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: randomised, double blind, placebo-controlled pilot trial. Kumpu M; Kekkonen RA; Korpela R; Tynkkynen S; Järvenpää S; Kautiainen H; Allen EK; Hendley JO; Pitkäranta A; Winther B Benef Microbes; 2015; 6(5):631-9. PubMed ID: 26322544 [TBL] [Abstract][Full Text] [Related]
3. The use of the probiotic Lactobacillus rhamnosus GG and viral findings in the nasopharynx of children attending day care. Kumpu M; Lehtoranta L; Roivainen M; Rönkkö E; Ziegler T; Söderlund-Venermo M; Kautiainen H; Järvenpää S; Kekkonen R; Hatakka K; Korpela R; Pitkäranta A J Med Virol; 2013 Sep; 85(9):1632-8. PubMed ID: 23794458 [TBL] [Abstract][Full Text] [Related]
4. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. Luoto R; Ruuskanen O; Waris M; Kalliomäki M; Salminen S; Isolauri E J Allergy Clin Immunol; 2014 Feb; 133(2):405-13. PubMed ID: 24131826 [TBL] [Abstract][Full Text] [Related]
5. Lactobacillus rhamnosus GG in the middle ear after randomized, double-blind, placebo-controlled oral administration. Tapiovaara L; Lehtoranta L; Swanljung E; Mäkivuokko H; Laakso S; Roivainen M; Korpela R; Pitkäranta A Int J Pediatr Otorhinolaryngol; 2014 Oct; 78(10):1637-41. PubMed ID: 25085073 [TBL] [Abstract][Full Text] [Related]
7. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171 [TBL] [Abstract][Full Text] [Related]
8. Recovery of probiotic Lactobacillus rhamnosus GG in tonsil tissue after oral administration: randomised, placebo-controlled, double-blind clinical trial. Kumpu M; Swanljung E; Tynkkynen S; Hatakka K; Kekkonen RA; Järvenpää S; Korpela R; Pitkäranta A Br J Nutr; 2013 Jun; 109(12):2240-6. PubMed ID: 23092692 [TBL] [Abstract][Full Text] [Related]
13. Role of rhinovirus load in the upper respiratory tract and severity of symptoms in lung transplant recipients. Ambrosioni J; Bridevaux PO; Aubert JD; Soccal P; Wagner G; Kaiser L J Clin Virol; 2015 Mar; 64():1-5. PubMed ID: 25728070 [TBL] [Abstract][Full Text] [Related]
14. Impact of Human Rhinovirus Types and Viral Load on the Severity of Illness in Hospitalized Children With Lower Respiratory Tract Infections. Xiao Q; Zheng S; Zhou L; Ren L; Xie X; Deng Y; Tian D; Zhao Y; Fu Z; Li T; Huang A; Liu E Pediatr Infect Dis J; 2015 Nov; 34(11):1187-92. PubMed ID: 26267309 [TBL] [Abstract][Full Text] [Related]
16. Comparison of virological profiles of respiratory syncytial virus and rhinovirus in acute lower tract respiratory infections in very young Chilean infants, according to their clinical outcome. Luchsinger V; Ampuero S; Palomino MA; Chnaiderman J; Levican J; Gaggero A; Larrañaga CE J Clin Virol; 2014 Sep; 61(1):138-44. PubMed ID: 24994006 [TBL] [Abstract][Full Text] [Related]